Correspondence | Published:

CTLA4Ig-based T-cell costimulation blockade is associated with reduction of adenovirus viremia following post-transplantation cyclophosphamide-based haploidentical transplantation

Bone Marrow Transplantation (2019) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Chakrabarti S, Mautner V, Osman H, Collingham KE, Fegan CD, Klapper PE, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood. 2002;100:1619–27. https://doi.org/10.1182/blood-2002-02-0377.

  2. 2.

    Robin M, Marque-Juillet S, Scieux C, Peffault de Latour R, Ferry C, Rocha V, et al. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica. 2007;92:1254–7.

  3. 3.

    van Tol MJ, Kroes AC, Schinkel J, Dinkelaar W, Claas EC, Jol-van der Zijde CM, et al. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transpl. 2005;36:39–50. https://doi.org/10.1038/sj.bmt.1705003.

  4. 4.

    Omar H, Yun Z, Lewensohn-Fuchs I, Perez-Bercoff L, Orvell C, Engstrom L, et al. Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia. Transpl Infect Dis. 2010;12:465–9. https://doi.org/10.1111/j.1399-3062.2010.00528.x.

  5. 5.

    Zecca M, Wynn R, Dalle J-H, Feuchtinger T, Vainorius E, Brundage TM, et al. Association between adenovirus viral load and mortality in pediatric allo-HCT recipients: the multinational AdVance study. Bone Marrow Transpl. 2019; https://doi.org/10.1038/s41409-019-0483-7.

  6. 6.

    Luznik L, O’Donnell PV, Fuchs EJ. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol. 2012;39:683–93. S0093-7754(12)00187-X, [pii];10.1053/j.seminoncol.2012.09.005 [doi]

  7. 7.

    Jaiswal SR, Bhakuni P, Joy A, Kaushal S, Chakrabarti A, Chakrabarti S. CTLA4Ig primed donor lymphocyte infusion: a novel approach to immunotherapy following haploidentical transplantation for advanced leukemia. Biol Blood Marrow Transpl. 2019. https://doi.org/10.1016/j.bbmt.2018.12.836.

  8. 8.

    Jaiswal SR, Bhakuni P, Joy A, Murli N, Rajoreya A, Chakrabarti A, et al. Higher CD45RA(+) regulatory T cells in the graft improves outcome in younger patients undergoing t cell-replete haploidentical transplantation: where donor age matters. Biol Blood Marrow Transpl. 2018;24:2025–33. https://doi.org/10.1016/j.bbmt.2018.06.003.

  9. 9.

    Jaiswal SR, Bhakuni P, Zaman S, Bansal S, Bharadwaj P, Bhargava S, et al. T cell costimulation blockade promotes transplantation tolerance in combination with sirolimus and post-transplantation cyclophosphamide for haploidentical transplantation in children with severe aplastic anemia. Transpl Immunol. 2017;43-44:54–9. https://doi.org/10.1016/j.trim.2017.07.004.

  10. 10.

    Jaiswal SR, Zaman S, Chakrabarti A, Sen S, Mukherjee S, Bhargava S, et al. Improved outcome of refractory/relapsed acute myeloid leukemia after post-transplantation cyclophosphamide-based haploidentical transplantation with myeloablative conditioning and early prophylactic granulocyte colony-stimulating factor-mobilized donor lymphocyte infusions. Biol Blood Marrow Transpl. 2016;22:1867–73. https://doi.org/10.1016/j.bbmt.2016.07.016.

  11. 11.

    Suparno C, Milligan DW, Moss PA, Mautner V. Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leuk Lymphoma. 2004;45:873–85. https://doi.org/10.1080/10428190310001628176.

  12. 12.

    Zaia J, Baden L, Boeckh MJ, Chakrabarti S, Einsele H, Ljungman P, et al. Viral disease prevention after hematopoietic cell transplantation. Bone Marrow Transpl. 2009;44:471–82. https://doi.org/10.1038/bmt.2009.258.

  13. 13.

    Matthes-Martin S, Feuchtinger T, Shaw PJ, Engelhard D, Hirsch HH, Cordonnier C, et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis. 2012;14:555–63. https://doi.org/10.1111/tid.12022.

  14. 14.

    Comoli P, Locatelli F, Moretta A, Montagna D, Calcaterra V, Cometa A, et al. Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses. Bone Marrow Transpl. 2001;27:1263–73.

  15. 15.

    Jaiswal SR, Bhakuni P, Joy A, Kaushal S, Sudhish D, Aiyer HM, et al. Early expansion of CD56dimNKG2Alow with late surge and persistence of CD56dimNKG2AnegNKG2Cbright NK cells attenuate cytomegalovirus (CMV) replication and recurrence as well as leukemia relapse following haploidentical HSCT with T cell co-stimulation blockade and PTCy. Biol Blood Marrow Transplant. 2019;25:S328. https://doi.org/10.1016/j.bbmt.2018.12.529.

  16. 16.

    Lugthart G, Oomen MA, Jol-van der Zijde CM, Ball LM, Bresters D, Kollen WJ, et al. The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution. Biol Blood Marrow Transpl. 2015;21:293–9. https://doi.org/10.1016/j.bbmt.2014.10.012.

  17. 17.

    Pinelli DF, Wakeman BS, Wagener ME, Speck SH, Ford ML. Rapamycin ameliorates the CTLA4-Ig-mediated defect in CD8(+) T cell immunity during gammaherpesvirus infection. Am J Transpl. 2015;15:2576–87. https://doi.org/10.1111/ajt.13326.

  18. 18.

    Davies J, Yuk D, Nadler L, Guinan E, Donor-Derived T. Cells can be rendered hyporesponsive to alloantigen without loss of pathogen or tumor immune responses. Blood. 2015;110:771.

  19. 19.

    Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+natural killer cells with potent function. Blood. 2012;119:2665–74. https://doi.org/10.1182/blood-2011-10-386995.

Download references

Author information

Affiliations

  1. Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, Kolkata, West Bengal, India

    • Sarita Rani Jaiswal
    • , Prakash Bhakuni
    • , Aditi Chakrabarti
    •  & Suparno Chakrabarti
  2. Department of Blood and Marrow Transplantation, Dharamshila Narayana Superspeciality Hospital and Research Centre, New Delhi, India

    • Sarita Rani Jaiswal
    • , Prakash Bhakuni
    • , Gitali Bhagawati
    •  & Suparno Chakrabarti

Authors

  1. Search for Sarita Rani Jaiswal in:

  2. Search for Prakash Bhakuni in:

  3. Search for Gitali Bhagawati in:

  4. Search for Aditi Chakrabarti in:

  5. Search for Suparno Chakrabarti in:

Contributions

SRJ and SC designed and performed the study; SRJ and PB performed the experiments; GB and PB collected the data and SRJ and SC analysed the data; SRJ, AC and SC wrote the paper. All the co-authors reviewed and approved the paper.

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Suparno Chakrabarti.

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/s41409-019-0549-6